Montreal researchers have discovered that a large share of commercially supplied research antibodies fail to work as intended, raising concerns about the reliability of experimental data. The team reported that these faulty reagents could produce inaccurate results and potentially lead to the publication of dubious studies. Antibodies are a cornerstone of biomedical investigations, yet many are sourced from private manufacturers whose products can differ in quality. The findings underscore the need for careful validation of these essential tools.